FAYSER is a pharmacy in Pont-à-Celles. Private Limited, started on 18 March 2025, 1 establishment.

What is the address of FAYSER?

The registered office of FAYSER is located at Rue Trieu-Braibant(PAC) 23, 6230 Pont-à-Celles.

Is FAYSER still active?

Yes. According to the CBE (29 October 2026) FAYSER is active, legal situation “Normale toestand”, started on 18 March 2025.

Is FAYSER registered on Peppol?

Yes, FAYSER is registered on the Peppol network with ID 0208:1021142358.

What is the enterprise number of FAYSER?

The enterprise number of FAYSER is BE1021142358.

When was FAYSER founded?

FAYSER was founded on 18 March 2025.

Is FAYSER a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 18 March 2025; 1 annual account filed (fiscal year 2025).

How much profit did FAYSER make in 2025?

FAYSER posted a profit after taxes of € 35,465 in financial year 2025.

What is the revenue of FAYSER?

As a small company, FAYSER is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 68,816.

FAYSER (Private Limited) - Pont-à-Celles - BE1021142358

Dossier FAYSER, printed on 29 October 2026 from databakkes.be/en/1021142358/fayser. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 6 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

FAYSER from Pont-à-Celles, company number BE1021142358, closed financial year 2025 with a result of € 35,465 after tax. For that financial year FAYSER recorded a gross margin of € 68,816 and equity of € 39,865. The company is profitable. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 17, 2026.

What it is worth Healthy

€ 39,865

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 35,465

Profit after tax over the fiscal year.

Cash in the bank

€ 30,217

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 1,600 paid out

5 % of the profit went to the shareholders, the rest stayed in the company.

Debts at end 2025

Bank debt ≈ 12 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 1.5 million

€ 126,280 is repaid this year. At this pace the long-term loan is gone in ≈ 12 years.

Owed to suppliers

€ 959

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 9,619

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

What happened to FAYSER?

What happened at FAYSER in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 17, 2026 New annual accounts for financial year 2025: profit of € 35,465. Source: NBB ↗
Mar 18, 2025 New establishment in Pont-à-Celles. KBO
Mar 18, 2025 Start of the company according to the CBE. KBO

In short

Paid € 10,470 in corporate taxes since 2025.

Paid out € 1,600 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Trieu-Braibant(PAC) 23

6230 Pont-à-Celles

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 1021.142.358
VAT number: BE 1021.142.358
Registered office: Rue Trieu-Braibant(PAC) 23, 6230 Pont-à-Celles
Names & denominations: FAYSER
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 18 March 2025
Peppol: Active · Active since 19 Dec 2025
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗

FAYSER